Avenue Therapeutics CEO Lucy Lu resigns; COO David Jin becomes interim principal executive officer

AVENUE THERAPEUTICS, INC.

Lucy Lu, M.D. resigned as President, CEO, and Board member effective March 31, 2022, to pursue an outside opportunity.
She entered into a consulting arrangement with the Company effective March 31, 2022.
David Jin, previously COO, will serve as interim principal executive officer from March 31, 2022.
Company continues evaluating potential strategic transaction options.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

David Jin

interim principal executive officer

ATXI · AVENUE THERAPEUTICS, INC.

Effective: 2022-03-31
Filed: March 30, 2022, 7:59 PM ET

David Jin, who was previously serving as the Company’s Chief Operating Officer, will begin acting as the Company’s interim principal executive officer as of March 31, 2022.

Departed

Lucy Lu

President and Chief Executive Officer

ATXI · AVENUE THERAPEUTICS, INC.

Effective: 2022-03-31
Successor: David Jin
Filed: March 30, 2022, 7:59 PM ET

Lucy Lu, M.D. notified Avenue Therapeutics, Inc. (the “Company”) that she was resigning from her role as the Company’s President and Chief Executive Officer, and from her position as a member of the Company’s Board of Directors, effective in each case as of March 31, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Jin was appointed as interim principal executive officer at AVENUE THERAPEUTICS, INC..

Action: appointed
Role: interim principal executive officer

Exact text from the filing

David Jin, who was previously serving as the Company’s Chief Operating Officer, will begin acting as the Company’s interim principal executive officer as of March 31, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lucy Lu resigned as President and Chief Executive Officer at AVENUE THERAPEUTICS, INC..

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Lucy Lu, M.D. notified Avenue Therapeutics, Inc. (the “Company”) that she was resigning from her role as the Company’s President and Chief Executive Officer, and from her position as a member of the Company’s Board of Directors, effective in each case as of March 31, 2022

View on SEC.gov

AVENUE THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-040209

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.